Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
33%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_4
1
8%
Ph phase_1
1
8%
Ph phase_3
1
8%
Ph not_applicable
8
62%
Ph phase_2
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(9)
Terminated(2)
Other(1)

Detailed Status

Completed9
Withdrawn1
Terminated1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 41 (8.3%)
N/A8 (66.7%)

Trials by Status

withdrawn18%
terminated18%
not_yet_recruiting18%
completed969%
unknown18%

Recent Activity

0 active trials
Showing 5 of 13
not_yet_recruitingnot_applicable

The Efficacy of Olfactory Cleft Steroid Drops in Patients With CRS With Olfactory Cleft Obstruction

NCT07386873
completedphase_1

The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus

NCT06851611
withdrawnphase_3

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

NCT04610801
completednot_applicable

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis

NCT05443945
completednot_applicable

A Usability Assessment of Naloxone by Community Members

NCT03309449
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07386873Not Applicable

The Efficacy of Olfactory Cleft Steroid Drops in Patients With CRS With Olfactory Cleft Obstruction

Not Yet Recruiting
NCT06851611Phase 1

The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus

Completed
NCT04610801Phase 3

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

Withdrawn
NCT05443945Not Applicable

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis

Completed
NCT03309449Not Applicable

A Usability Assessment of Naloxone by Community Members

Completed
NCT05639959

Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial

Completed
NCT05618483Not Applicable

Xylitol Based Nasal Spray for COVID-19 Treatment

Unknown
NCT05290987Not Applicable

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.

Terminated
NCT04681001Not Applicable

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Completed
NCT04532762Not Applicable

Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.

Completed
NCT04531358Not Applicable

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

Completed
NCT02275364Phase 4

Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion

Completed
NCT00620854Phase 2

A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women

Completed

All 13 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
13